NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger(Takeda (United States)), Douglas E. Wood(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dara L. Aisner(University of Colorado Cancer Center), Wallace Akerley(University of Utah), Jessica R. Bauman(Fox Chase Cancer Center), Ankit Bharat(Takeda (United States)), Débora S. Bruno(Cleveland Clinic), Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Lucian R. Chirieac(Takeda (United States)), Thomas A. D’Amico(Cancer Institute (WIA)), Thomas J. Dilling(Moffitt Cancer Center), Jonathan E. Dowell(Southwestern Medical Center), Scott Gettinger(Takeda (United States)), Matthew A. Gubens(Takeda (United States)), Aparna Hegde(University of Colorado Cancer Center), Mark Hennon(Takeda (United States)), Rudy P. Lackner(Susan Thompson Buffett Foundation), Michael Lanuti(Massachusetts General Hospital), Ticiana Leal(University of Wisconsin Carbone Cancer Center), Jules Lin(University of Michigan), Billy W. Loo(Cancer Institute (WIA)), Christine M. Lovly(Breast Cancer Research Foundation), Renato Martins(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Erminia Massarelli(City Of Hope National Medical Center), Daniel Morgensztern(Barnes-Jewish Hospital), Thomas Ng(University of Tennessee Health Science Center), Gregory A. Otterson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sandip Pravin Patel(University of California San Diego), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Steven E. Schild(Takeda (United States)), Theresa A. Shapiro(Takeda (United States)), Aditi P. Singh(Takeda (United States)), James Stevenson(Cleveland Clinic), Alda L. Tam(The University of Texas MD Anderson Cancer Center), Jane Yanagawa(Takeda (United States)), Stephen C. Yang(Takeda (United States)), Kristina M. Gregory(Pancreatic Cancer Action Network), Miranda Hughes(Pancreatic Cancer Action Network)
Cited by 1,003Open Access
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.
Related Papers
No related papers found
Powered by citation graph analysis